160 related articles for article (PubMed ID: 35488712)
1. Does minimal central nervous system involvement in childhood acute lymphoblastic leukemia increase the risk for central nervous system toxicity?
Anastasopoulou S; Harila-Saari A; Als-Nielsen B; Eriksson MA; Heyman M; Johannsdottir IM; Marquart HV; Niinimäki R; Pronk CJ; Schmiegelow K; Vaitkeviciene G; Thastrup M; Ranta S
Pediatr Blood Cancer; 2022 Jul; 69(7):e29745. PubMed ID: 35488712
[TBL] [Abstract][Full Text] [Related]
2. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease.
Anastasopoulou S; Eriksson MA; Heyman M; Wang C; Niinimäki R; Mikkel S; Vaitkevičienė GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Harila-Saari A; Ranta S
Pediatr Blood Cancer; 2019 May; 66(5):e27594. PubMed ID: 30592147
[TBL] [Abstract][Full Text] [Related]
3. Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes.
Anastasopoulou S; Nielsen RL; Als-Nielsen B; Banerjee J; Eriksson MA; Helenius M; Heyman MM; Johannsdottir IM; Jonsson OG; MacGregor S; Mateos MK; Mayoh C; Mikkel S; Myrberg IH; Niinimäki R; Schmiegelow K; Taskinen M; Vaitkeviciene G; Warnqvist A; Wolthers B; Harila-Saari A; Ranta S
Haematologica; 2022 Oct; 107(10):2318-2328. PubMed ID: 35354251
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous occurrence of posterior reversible leukoencephalopathy syndrome in two cases of childhood acute lymphoblastic leukemia induction chemotherapy.
Gupta A; Swaroop C; Rastogi R; Garg R; Bakhshi S
Pediatr Hematol Oncol; 2008 Jun; 25(4):351-8. PubMed ID: 18484481
[TBL] [Abstract][Full Text] [Related]
5. Patterns and Outcomes of Acute Central Nervous System Complications During Treatment of Childhood Acute Lymphoblastic Leukemia: A Single-center Experience.
Hamoda A; Bedair M; Semary SF; Youssef A; Hafez H
J Pediatr Hematol Oncol; 2024 Mar; 46(2):72-79. PubMed ID: 38132573
[TBL] [Abstract][Full Text] [Related]
6. Flow Cytometric Detection of Malignant Blasts in Cerebrospinal Fluid: A Biomarker of Central Nervous System Involvement in Childhood Acute Lymphoblastic Leukemia.
Thastrup M; Marquart HV; Schmiegelow K
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740938
[TBL] [Abstract][Full Text] [Related]
7. Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management.
Paul S; Short NJ
Curr Oncol Rep; 2022 Apr; 24(4):427-436. PubMed ID: 35141858
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions.
Thastrup M; Duguid A; Mirian C; Schmiegelow K; Halsey C
Leukemia; 2022 Dec; 36(12):2751-2768. PubMed ID: 36266325
[TBL] [Abstract][Full Text] [Related]
9. Posterior Reversible Encephalopathy Syndrome: Risk Factors and Impact on the Outcome in Children With Acute Lymphoblastic Leukemia Treated With Nordic Protocols.
Banerjee JS; Heyman M; Palomäki M; Lähteenmäki P; Arola M; Riikonen PV; Möttönen MI; Lönnqvist T; Taskinen MH; Harila-Saari AH
J Pediatr Hematol Oncol; 2018 Jan; 40(1):e13-e18. PubMed ID: 29200159
[TBL] [Abstract][Full Text] [Related]
10. Seizures during treatment of childhood acute lymphoblastic leukemia: A population-based cohort study.
Anastasopoulou S; Heyman M; Eriksson MA; Niinimäki R; Taskinen M; Mikkel S; Vaitkeviciene GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Ranta S; Harila-Saari A
Eur J Paediatr Neurol; 2020 Jul; 27():72-77. PubMed ID: 32340855
[TBL] [Abstract][Full Text] [Related]
11. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
Thomas X; Pavan L; Le QH
Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
[TBL] [Abstract][Full Text] [Related]
12. Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study.
Parasole R; Petruzziello F; Messina C; Barisone E; Pession A; Locatelli F; Micalizzi C; Cesaro S; Testi AM; De Matteo A; Varotto S; Berger M; Morello W; Menna G; Poggi V
Leuk Lymphoma; 2015 Mar; 56(3):650-5. PubMed ID: 24882262
[TBL] [Abstract][Full Text] [Related]
13. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia.
Levinsen M; Taskinen M; Abrahamsson J; Forestier E; Frandsen TL; Harila-Saari A; Heyman M; Jonsson OG; Lähteenmäki PM; Lausen B; Vaitkevičienė G; Asberg A; Schmiegelow K;
Pediatr Blood Cancer; 2014 Aug; 61(8):1416-21. PubMed ID: 24623619
[TBL] [Abstract][Full Text] [Related]
15. Study of Posterior Reversible Encephalopathy Syndrome in Children With Acute Lymphoblastic Leukemia After Induction Chemotherapy.
Tang JH; Tian JM; Sheng M; Hu SY; Li Y; Zhang LY; Gu Q; Wang Q
J Child Neurol; 2016 Mar; 31(3):279-84. PubMed ID: 26060305
[TBL] [Abstract][Full Text] [Related]
16. Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group.
Tsurusawa M; Katano N; Yamamoto Y; Hirota T; Koizumi S; Watanabe A; Takeda T; Hatae Y; Yatabe M; Mimaya J; Gushiken T; Nishi K; Anami K; Kikuta A; Kanegane H; Asami K; Nishikawa K; Sekine I; Kawano Y; Iwai A; Furuyama T; Ijichi O; Miyake M; Mugishima H; Fujimoto T
Med Pediatr Oncol; 1999 Apr; 32(4):259-6. PubMed ID: 10102019
[TBL] [Abstract][Full Text] [Related]
17. Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid.
Ranta S; Nilsson F; Harila-Saari A; Saft L; Tani E; Söderhäll S; Porwit A; Hultdin M; Noren-Nyström U; Heyman M
Pediatr Blood Cancer; 2015 Jun; 62(6):951-6. PubMed ID: 25545289
[TBL] [Abstract][Full Text] [Related]
18. Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study.
Winick NJ; Smith SD; Shuster J; Lauer S; Wharam MD; Land V; Buchanan G; Rivera G
J Clin Oncol; 1993 Feb; 11(2):271-8. PubMed ID: 8426204
[TBL] [Abstract][Full Text] [Related]
19. The spectrum of acute central nervous system symptoms during the treatment of childhood acute lymphoblastic leukaemia.
Banerjee J; Niinimäki R; Lähteenmäki P; Hed Myrberg I; Arola M; Riikonen P; Lönnqvist T; Palomäki M; Ranta S; Harila-Saari A; Taskinen M
Pediatr Blood Cancer; 2020 Feb; 67(2):e27999. PubMed ID: 31674724
[TBL] [Abstract][Full Text] [Related]
20. The effect of central nervous system involvement and irradiation in childhood acute lymphoblastic leukemia: Lessons from the NOPHO ALL-92 and ALL-2000 protocols.
Taskinen M; Oskarsson T; Levinsen M; Bottai M; Hellebostad M; Jonsson OG; Lähteenmäki P; Schmiegelow K; Heyman M
Pediatr Blood Cancer; 2017 Feb; 64(2):242-249. PubMed ID: 27748030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
